Release date: 2016-07-11
Recently, Google's UK subsidiary DeepMind announced a new research project that will use artificial intelligence to diagnose and treat eye diseases that can cause blindness in collaboration with the National Health Service (NHS) Hospital Moorfields Hospital.
The project is the second collaboration between DeepMind and DHS, but the first collaboration did not use artificial intelligence. Through millions of eye scans, research partners will develop how to use machine learning to help analyze the results of eye CT examinations, and to establish algorithms that can early warning of two special eye diseases—wet age-related macular degeneration and diabetic retina. Lesion. The project's intended goal is to ultimately diagnose these diseases with a digital scan using artificial intelligence.
Dr. Pearse Keane of Moorfields Hospital contacted DeepMind to facilitate this collaboration and seek ways to treat both diseases. Nearly 100 million people worldwide are affected by these two eye diseases. Diabetic retinopathy is the fastest eye disease that has progressed to blindness.
The study does not currently improve the current patient condition. Moorfields Hospital will share data on routine eye exams with DeepMind, which will help developers develop the fastest way to check and intervene in visual deterioration. Currently, ophthalmologists digitally scan the fundus through OCT. The OCT process is complex and time consuming, and traditional computational analysis tools are not able to meet today's needs.
Google acquired DeepMind in January 2014. In February of this year, Google DeepMind announced a partnership with NHS to develop medical apps. An app is Streams that can provide doctors with information on patients with acute kidney failure. The other is Hark, which organizes the current handwritten notes for doctors and nurses.
For the early NHSapp R&D project, DeepMind can access nursing information for approximately 1.6 million patients. The information security of the project is controversial.
However, the company said that the ophthalmic scans are anonymous, and it is impossible to get information from a patient scan. Historically scanned information will be used to improve the patient's future medical condition and current patient care is not affected.
Original link: http://mobihealthnews.com/content/google-deepmind-announces-research-project-nhs-detect-eye-diseases
Source: Kexun Medical Network
Peptides,Human Growth Hormone,Melanotan2,Ghrp
Shaanxi Hongbaiyi Biotech Co., Ltd. , https://www.sxhongbaiyi.com